Literature DB >> 16825388

Lamivudine resistance of hepatitis B virus masked by coemergence of mutations in probe region of the COBAS AMPLICOR assay.

Magnus Lindh1, Charles Hannoun, Sebastian Malmström, Johan Lindberg, Gunnar Norkrans.   

Abstract

The COBAS AMPLICOR hepatitis B virus assay targets a conserved region of the genome and is widely used to monitor treatment of hepatitis B in order to identify emerging resistance. However, the assay failed to recognize increasing viremia levels when YMDD mutations were paralleled by mutations in the segment targeted by the COBAS AMPLICOR probe.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16825388      PMCID： PMC1489515          DOI： 10.1128/JCM.00265-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Phylogenetic origin of hepatitis B virus strains with precore C-1858 variant.

Authors:  E Alestig; C Hannoun; P Horal; M Lindh
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Dynamic range and reproducibility of hepatitis B virus (HBV) DNA detection and quantification by Cobas Taqman HBV, a real-time semiautomated assay.

Authors:  Magnus Lindh; Charles Hannoun
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test.

Authors:  U Noborg; A Gusdal; E K Pisa; A Hedrum; M Lindh
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

4.  Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.

Authors:  G A Tipples; M M Ma; K P Fischer; V G Bain; N M Kneteman; D L Tyrrell
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

5.  Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

Authors:  K M Weinberger; E Wiedenmann; S Böhm; W Jilg
Journal:  J Virol Methods       Date:  2000-03       Impact factor: 2.014

6.  High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.

Authors:  H Bozkaya; B Ayola; A S Lok
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

7.  Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Authors:  Frank Tacke; Christina Gehrke; Tom Luedde; Albert Heim; Michael P Manns; Christian Trautwein
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro.

Authors:  Robert Y m Chen; Ros Edwards; Tim Shaw; Danni Colledge; William E Delaney; Harriet Isom; Scott Bowden; Paul Desmond; Stephen A Locarnini
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425
  8 in total
  9 in total

1.  A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.

Authors:  Laure Boizeau; Annabelle Servant-Delmas; Alexandra Ducancelle; Stéphane Chevaliez; Vincent Thibault; Syria Laperche; Pierre Cappy
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimens.

Authors:  Gavin A Cloherty; James Rhoads; Thomas P Young; Neil T Parkin; Vera Holzmayer; Lilly Yuen; Carolyn Mullen
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

3.  HBV DNA Test Among Blood Donations May Require Two Amplification Targets.

Authors:  Chao Liu; Le Chang; Lunan Wang
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-18       Impact factor: 0.900

4.  Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections.

Authors:  Vincent Thibault; Christian Pichoud; Carolyn Mullen; James Rhoads; Jane B Smith; Alain Bitbol; Sven Thamm; Fabien Zoulim
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

5.  Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection.

Authors:  Shipeng Sun; Shuang Meng; Rui Zhang; Kuo Zhang; Lunan Wang; Jinming Li
Journal:  Virol J       Date:  2011-05-14       Impact factor: 4.099

6.  Real-time PCR assays for hepatitis B virus DNA quantification may require two different targets.

Authors:  Chao Liu; Le Chang; Tingting Jia; Fei Guo; Lu Zhang; Huimin Ji; Junpeng Zhao; Lunan Wang
Journal:  Virol J       Date:  2017-05-12       Impact factor: 4.099

7.  Comparison of the QIAGEN artus HBV QS-RGQ Assay With the Roche COBAS AmpliPrep/COBAS TaqMan HBV Assay for Quantifying Viral DNA in Sera of Chronic Hepatitis B Patients.

Authors:  Mi Soon Han; Yongjung Park; Hyunjin Nah; Hyon Suk Kim
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

8.  Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples.

Authors:  Ying Yan; Le Chang; Huimin Ji; Yang Han; Lunan Wang
Journal:  Microbiol Spectr       Date:  2022-07-26

9.  Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.

Authors:  Ming-Lun Yeh; Chung-Feng Huang; Ching-I Huang; Shu-Fen Liu; Hua-Ling Yang; Ming-Yen Hsieh; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.